Status:

COMPLETED

Efficacy and Safety Comparison Between SMOFlipid and Lipovenoes MCT

Lead Sponsor:

National Taiwan University Hospital

Conditions:

Gastrectomy

Malnutrition

Eligibility:

All Genders

25-75 years

Phase:

PHASE4

Brief Summary

Comparison of efficacy and safety of two lipid emulsion products will be performed on gastrectomy patients postsurgically.

Detailed Description

The comparison of two lipid emulsion product will be performed. Patients who plan to accept gastrectomy will be consider for trial and signed content will be obtained. If the patient needs total paren...

Eligibility Criteria

Inclusion

  • Age between 25 \~ 75 years old
  • Postoperative (gastrectomy) patients required parental nutrition for at least 5 days
  • Signed informed consent form

Exclusion

  • Known hypersensitivity to fish-, egg- or soy protein or to any of the active substances or excipients
  • Known type IV hyperlipidemia, disturbances in lipid metabolism or hypertriglyceridemia. If the fasting S-triglyceride value at the time of inclusion is \>2.26 mmol/l (\>200 mg/dl) the subject must not be included
  • Severe liver insufficiency (total serum bilirubin ≧ 3 mg/dL or parental nutrition as a contraindication.)
  • Severe renal insufficiency with need for dialysis, chronic stable renal insufficiency defined as S-creatinine value of \>3mg/dL (250 µmol/l), or dialysis/hemofiltration therapy
  • Over weight (BMI\> 30kg/m2)
  • Severe blood coagulation disorders
  • Inborn abnormality in amino acid metabolism
  • Unstable conditions (e.g. severe post-traumatic conditions, uncompensated diabetes mellitus, acute myocardial infarction, stroke, embolism, metabolic acidosis, severe sepsis and hypotonic dehydration)
  • Known diabetic ketoacidosis 7 days prior to randomization.
  • Acute shock
  • General contraindications to infusion therapy: acute pulmonary oedema, hyperhydration, decompensated cardiac insufficiency
  • Pregnancy or lactation
  • Chemotherapy within 7 days before start of the trial
  • Participation in another clinical study with an investigational drug or an investigational medical device within 1 month prior to start of study or during the study
  • Already accept parental nutrition therapy.

Key Trial Info

Start Date :

November 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2010

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT00885781

Start Date

November 1 2008

End Date

December 1 2010

Last Update

October 17 2011

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

National Taiwan University Hospital

Taipei, Taipei, Taiwan, 10002